THE EFFECTIVENESS OF THE LAVOMAX USE IN COMPLEX TREATMENT OF PATIENTS WITH CHRONICLE BACTERIAL PROSTATITIS

Abstract

THE AIM of the investigation is the evaluation of the effectiveness of the lavomax use in patients with chronicle bacterial prostatitis. PATIENTS AND METHODS. The objects of the investigation were 59 patients who were divided in the control and basic group. The control group included 24 patients, who had traditional therapy of the chronicle bacterial prostatitis, and the basic group – of 35 patients, who besides traditional therapy in addition received immunomodulator Lavomax. RESULTS. After the three weeks of treatment the patients of the basic group had an increase in T-lymphocytes amount from 43,2±3,4 to 62,10±3,17%, with full normalization in 32 patients (91,4%), while in the control group this figure came to normal amount only in 16 patients (67%). Lavomax increased the functional activity of T-lymphocytes. More obvious was the increase of blood T-helpers – from 30,2±3,4% to 36,7± 3,8 5 in the basic group, and also with the increase of the T-suppressor/T-helper ratio from  0,93±0,21 to 1,73±0,19. Lavomax had a positive influence on humoral immune system, with the increase of IgA level from 0,78±0,17 g/l to 4,12±1,18 g/l, in control group this figure did not show relative change. CONCLUSION. The received data demonstrates the effectiveness of immunotherapy with the use of Lavomax in patients with chronicle bacterial prostatitis.